LFWD
Price
$1.14
Change
-$0.06 (-5.00%)
Updated
Jun 12 closing price
Capitalization
44.44M
54 days until earnings call
SRDX
Price
$29.08
Change
+$0.09 (+0.31%)
Updated
Jun 12 closing price
Capitalization
397.04M
47 days until earnings call
Interact to see
Advertisement

LFWD vs SRDX

Header iconLFWD vs SRDX Comparison
Open Charts LFWD vs SRDXBanner chart's image
Lifeward
Price$1.14
Change-$0.06 (-5.00%)
Volume$137.03K
Capitalization44.44M
Surmodics
Price$29.08
Change+$0.09 (+0.31%)
Volume$77.44K
Capitalization397.04M
LFWD vs SRDX Comparison Chart
Loading...
LFWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFWD vs. SRDX commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFWD is a StrongBuy and SRDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2025
Stock price -- (LFWD: $1.20 vs. SRDX: $28.99)
Brand notoriety: LFWD and SRDX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LFWD: 151% vs. SRDX: 65%
Market capitalization -- LFWD: $44.44M vs. SRDX: $397.04M
LFWD [@Medical Specialties] is valued at $44.44M. SRDX’s [@Medical Specialties] market capitalization is $397.04M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFWD’s FA Score shows that 1 FA rating(s) are green whileSRDX’s FA Score has 0 green FA rating(s).

  • LFWD’s FA Score: 1 green, 4 red.
  • SRDX’s FA Score: 0 green, 5 red.
According to our system of comparison, LFWD is a better buy in the long-term than SRDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFWD’s TA Score shows that 5 TA indicator(s) are bullish while SRDX’s TA Score has 4 bullish TA indicator(s).

  • LFWD’s TA Score: 5 bullish, 3 bearish.
  • SRDX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LFWD is a better buy in the short-term than SRDX.

Price Growth

LFWD (@Medical Specialties) experienced а -2.44% price change this week, while SRDX (@Medical Specialties) price change was -3.33% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.00%. For the same industry, the average monthly price growth was +1.65%, and the average quarterly price growth was +1.66%.

Reported Earning Dates

LFWD is expected to report earnings on Aug 06, 2025.

SRDX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+1.00% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRDX($397M) has a higher market cap than LFWD($44.4M). SRDX YTD gains are higher at: -26.566 vs. LFWD (-34.104). SRDX has higher annual earnings (EBITDA): 22.1M vs. LFWD (-21.77M). SRDX has more cash in the bank: 35.2M vs. LFWD (28.1M). LFWD has less debt than SRDX: LFWD (1.9M) vs SRDX (33.9M). SRDX has higher revenues than LFWD: SRDX (138M) vs LFWD (13.9M).
LFWDSRDXLFWD / SRDX
Capitalization44.4M397M11%
EBITDA-21.77M22.1M-98%
Gain YTD-34.104-26.566128%
P/E RatioN/A71.51-
Revenue13.9M138M10%
Total Cash28.1M35.2M80%
Total Debt1.9M33.9M6%
FUNDAMENTALS RATINGS
LFWD vs SRDX: Fundamental Ratings
LFWD
SRDX
OUTLOOK RATING
1..100
5224
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9893
PRICE GROWTH RATING
1..100
8959
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LFWD's Valuation (27) in the Medical Specialties industry is somewhat better than the same rating for SRDX (92). This means that LFWD’s stock grew somewhat faster than SRDX’s over the last 12 months.

LFWD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SRDX (100). This means that LFWD’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's SMR Rating (93) in the Medical Specialties industry is in the same range as LFWD (98). This means that SRDX’s stock grew similarly to LFWD’s over the last 12 months.

SRDX's Price Growth Rating (59) in the Medical Specialties industry is in the same range as LFWD (89). This means that SRDX’s stock grew similarly to LFWD’s over the last 12 months.

SRDX's P/E Growth Rating (94) in the Medical Specialties industry is in the same range as LFWD (100). This means that SRDX’s stock grew similarly to LFWD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFWDSRDX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend about 1 month ago
74%
Bullish Trend 16 days ago
67%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
LFWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SILVX17.780.16
+0.91%
SGI US Large Cap Equity I
FEBRX14.700.10
+0.68%
First Eagle Global Income Builder R6
FEQIX78.03N/A
N/A
Fidelity Equity-Income
SAOAX30.55N/A
N/A
NAA Opportunity Fund A
FCLAX50.97N/A
N/A
Fidelity Advisor Industrials A

LFWD and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFWD has been loosely correlated with NNOX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LFWD jumps, then NNOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFWD
1D Price
Change %
LFWD100%
-5.00%
NNOX - LFWD
37%
Loosely correlated
-4.62%
DHAI - LFWD
32%
Poorly correlated
-5.86%
BMRA - LFWD
32%
Poorly correlated
-3.21%
ESTA - LFWD
29%
Poorly correlated
-3.68%
SRDX - LFWD
29%
Poorly correlated
+0.31%
More

SRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with PXMBF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then PXMBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
+0.31%
PXMBF - SRDX
41%
Loosely correlated
N/A
BDX - SRDX
30%
Poorly correlated
+1.01%
BLCO - SRDX
29%
Poorly correlated
-0.56%
TFX - SRDX
29%
Poorly correlated
-0.30%
LFWD - SRDX
29%
Poorly correlated
-5.00%
More